# MyOme

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myome

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.myome.com
- Total disclosed funding: $23M
- Latest round: Series B (Jun 21, 2022)
- Investors on record: 8

## About

Founded in 2017 and based in California, US, MyOme Inc. is a biotech company that helps families and individuals to understand and identify genes and diseases that are inherited from their family. The company is certified under the Clinical Laboratory Improvement Amendments (CLIA) and is led by CEO Premal Shah, PhD. Founders of the company include Matthew Rabinowitz, co-founder of Natera, Kate Im, and Akash Kumar. 

In October 2019, MyOme Inc. raised Series A funding from new investors HOF Capital and Norwest Venture Partners. And in June 2022, MyOme raised USD 32 million in Series B funding led by new investors HealthCare Ventures, with participation from other new investors Foresite Capital, Founders Fund, Natera Inc., SBI Investment, and Sequoia Capital as well as unspecified investors. The Series B funding values MyOme Inc. at USD 132 million post-money.   

The company offers a complete analysis of disease risk through clinical-grade whole genome sequencing. MyOme analyzes the DNA data and provides proactive health and pharmacogenomics reports on-demand to answer clinically relevant questions throughout a patient’s life related to risk for cardiac, diabetes, autoimmune, cancer risk, and other conditions, response to certain medications, single gene and polygenic analysis to assess the risk of multifactorial diseases, rare diseases, and pharmacogenomics.

## Funding rounds

- Series B, Jun 21, 2022, $23M — HealthCare Ventures, Hong Shan, Founders Fund, Natera, Inc., Foresite Capital, SBI Investment
- Series B, Dec 7, 2021 — Norwest Venture Partners
- Series A, Oct 23, 2019 — Norwest Venture Partners, HOF Capital

## Investors

- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series A, Series B
- HOF Capital (https://capitalatlas.ai/funds/hof-capital) — Series A
- HealthCare Ventures — Series B
- Hong Shan — Series B
- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series B
- Natera, Inc. — Series B
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series B
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series B